Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
24.22
-0.72 (-2.89%)
May 20, 2026, 11:29 AM CST
SHA:600993 Market Cap
SHA:600993 has a market cap or net worth of 10.75 billion as of May 19, 2026. Its market cap has decreased by -7.04% in one year.
Market Cap
10.75B
Enterprise Value
8.40B
Revenue
3.91B
Ranking
n/a
PE Ratio
18.20
Stock Price
24.22
Market Cap Chart
Since June 22, 2004, SHA:600993's market cap has increased from 1.07B to 10.75B, an increase of 900.45%. That is a compound annual growth rate of 11.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 10.71B | -11.25% |
| Dec 31, 2025 | 12.07B | 7.24% |
| Dec 31, 2024 | 11.25B | 7.98% |
| Dec 29, 2023 | 10.42B | 6.99% |
| Dec 30, 2022 | 9.74B | -21.42% |
| Dec 31, 2021 | 12.40B | 42.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Henan Lingrui Pharmaceutical | 12.42B |
| Shanghai Shyndec Pharmaceutical | 12.42B |
| Ningbo Menovo Pharmaceutical | 12.02B |
| Zhejiang Jingxin Pharmaceutical | 11.60B |
| Wanbangde Pharmaceutical Holding Group | 11.57B |
| Zhejiang Jiuzhou Pharmaceutical | 11.45B |
| Guangdong Taienkang Pharmaceutical | 11.39B |
| Zhejiang CONBA Pharmaceutical | 10.93B |